Alzheimer Disease Gene Review Project
Bottom line: Alzheimer disease genetics points at a handful of mechanisms:
amyloid precursor protein (APP) processing by the beta- and gamma-secretases,
tau, lipid and apolipoprotein transport, endocytosis, and microglial innate
immunity. We reviewed every existing GO annotation on a 34-gene human seed set
spanning those mechanisms, from the familial genes (APP, PSEN1, PSEN2) through
GWAS and rare-variant risk genes (APOE, TREM2, SORL1, PLCG2, ABI3) to the
pathway genes needed for module curation. All 34 reviews are marked COMPLETE
and cover 4,336 annotations: 2,362 ACCEPT, 1,178 KEEP_AS_NON_CORE, 630
MARK_AS_OVER_ANNOTATED, 124 MODIFY, 4 REMOVE, 34 UNDECIDED and 4 NEW. The low
REMOVE count reflects a deliberate choice to leave abstract-only experimental
rows UNDECIDED rather than overrule curators. The reusable normal-biology
modules proposed below (APP processing, gamma-secretase proteolysis, tau
microtubule biology and others) have not been built yet. A few per-gene action
counts in the dated notes below differ slightly from the current review files,
which were edited after the notes were written.
We did this because AD genes carry some of the largest annotation sets in
human GO (APP alone has 429 rows, GSK3B 390), so a disease-anchored gene set
tests whether review can separate each gene's core molecular function from its
pleiotropic and disease-context annotations.
Overview
This project reviews human GO annotations for genes central to Alzheimer disease
genetics and biology. The scope combines Mendelian/familial Alzheimer disease
genes, high-confidence common and rare variant risk genes, and pathway genes
needed to curate reusable disease-relevant modules.
The initial project focus is human Alzheimer disease (MONDO:0004975). Disease
scope, gene-set rationale, and prioritization belong in this project page;
reusable modules/ entries should be normal biological pathways, complexes, or
motifs rather than disease-project overviews.
Model Species
Primary: Homo sapiens (human)
- UniProt species code: HUMAN
- Review scope: human gene annotation reviews plus pathway/module curation
- Initial gene set: bounded seed list for review; not every included gene is
asserted to be independently causal for Alzheimer disease
Genes for Review
Priority 1: Foundational Alzheimer Genetics
| Gene | Rationale |
|---|---|
| APP | Amyloid precursor protein; central substrate for amyloid beta production |
| PSEN1 | Familial Alzheimer disease presenilin; gamma-secretase catalytic subunit |
| PSEN2 | Familial Alzheimer disease presenilin; gamma-secretase catalytic subunit |
| APOE | Major late-onset Alzheimer disease risk locus; lipid transport and amyloid clearance |
| TREM2 | Rare-variant microglial risk gene; innate immune signaling |
| SORL1 | Endosomal APP trafficking and amyloid processing risk gene |
| ABCA7 | Lipid transport/phagocytosis risk gene |
| ADAM10 | Alpha-secretase in non-amyloidogenic APP processing |
Priority 2: Amyloid Processing and Tau Biology
| Gene | Module context |
|---|---|
| BACE1 | Beta-secretase initiating amyloidogenic APP processing |
| NCSTN | Gamma-secretase complex maturation and substrate recognition |
| APH1A | Gamma-secretase complex subunit |
| APH1B | Gamma-secretase complex subunit; AD-associated target signal in Open Targets |
| PSENEN | Gamma-secretase complex stabilizing subunit |
| MAPT | Tau pathology axis; microtubule-associated tau |
| GSK3B | Tau phosphorylation and kinase signaling context |
| CDK5 | Neuronal kinase implicated in tau phosphorylation biology |
| CDK5R1 | CDK5 regulatory subunit; neuronal kinase activation context |
Priority 3: Lipid, Endocytosis, Complement, and Microglial Risk Network
| Gene | Module context |
|---|---|
| CLU | Apolipoprotein/chaperone risk gene; amyloid handling and complement context |
| BIN1 | Endocytosis and membrane remodeling risk gene |
| PICALM | Clathrin-mediated endocytosis and APP/ApoE trafficking risk gene |
| CD33 | Microglial immune receptor risk gene |
| CR1 | Complement receptor risk gene |
| CD2AP | Endocytosis/cytoskeletal adaptor risk gene |
| INPP5D | SHIP1; microglial phosphoinositide signaling risk gene |
| PLCG2 | Rare coding variant microglial signaling risk gene |
| ABI3 | Rare coding variant microglial cytoskeletal/immune risk gene |
| SPI1 | PU.1 transcription factor; myeloid/microglial regulatory risk locus |
| MS4A4A | MS4A locus representative; microglial/lipid biomarker genetics |
| MS4A6A | MS4A locus representative; Alzheimer disease GWAS signal |
| EPHA1 | Endocytosis/immune signaling risk gene |
| FERMT2 | Integrin/cytoskeletal adaptor risk gene |
| CASS4 | Cytoskeletal adaptor risk gene |
| LRP1 | ApoE receptor and APP/amyloid clearance pathway component |
| ABCA1 | ApoE lipidation and cholesterol efflux pathway component |
Reusable Normal-Biology Modules
Curate reusable pathway and complex models as ModuleReview YAML files under
modules/ only when the module is a normal biological unit with a normal
biology name. Alzheimer relevance can be recorded here in the project page and
in gene reviews, but the module title/scope should stay biological rather than
disease-project scoped.
Candidate normal-biology modules for future curation include APP processing and
amyloid-beta handling, gamma-secretase-mediated intramembrane proteolysis,
apolipoprotein/lipoprotein transport, microglial lipid-debris sensing, tau
microtubule biology, and endocytic adaptor trafficking.
Validate each module with:
uv run linkml-validate -s src/ai_gene_review/schema/gene_review.yaml -C ModuleReview modules/<module>.yaml
Source Anchors
- Open Targets Platform query for Alzheimer disease (
MONDO_0004975), accessed
2026-06-19. Top associated targets included APP, PSEN1, PSEN2, APOE, SORL1,
ADAM10, TREM2, ABCA7, CLU, BIN1, PLCG2, and APH1B. - GWAS Catalog REST query for
efo_trait=Alzheimer disease, accessed
2026-06-19, used to confirm the disease trait mapping and GWAS context. - Bellenguez et al. 2022, "New insights into the genetic etiology of Alzheimer's
disease and related dementias" (PMID 35379992). - Kunkle et al. 2019, "Genetic meta-analysis of diagnosed Alzheimer's disease
identifies new risk loci and implicates amyloid beta, tau, immunity and lipid
processing" (PMID 30820047). - Sims et al. 2017, "Rare coding variants in PLCG2, ABI3, and TREM2 implicate
microglial-mediated innate immunity in Alzheimer's disease"
(PMID 28714976).
STATUS
- [x] Create project scope and seed gene list
- [x] Fetch UniProt, GOA, and publication caches for all frontmatter genes
- [x] Run deep research or record manual notes for Priority 1 genes
- [x] Complete Priority 1 gene annotation reviews
- [x] Retire disease-project overview from
modules/; keep Alzheimer scope as a project - [x] Review Priority 2 and Priority 3 genes
- [x] Render project page and update project index
NOTES
2026-06-19
- Created project scaffold with 34 human seed genes.
- Seed list is intentionally mixed: Mendelian AD genes, late-onset AD risk genes,
and mechanistic pathway genes required for module curation. - Open Targets and GWAS Catalog were used as scoping anchors; per-gene reviews
still need the standardjust fetch-gene human <GENE>and deep-research steps
before curation decisions. - Fetched and seeded missing Priority 1 gene data for PSEN1, PSEN2, APOE, TREM2,
SORL1, ABCA7, and ADAM10. Publication-cache confirmation is complete for these
genes: PSEN1 57/57, PSEN2 18/18, APOE 104/104, TREM2 31/31, SORL1 34/34,
ABCA7 7/7, and ADAM10 44/44. Falcon deep research for PSEN1 stalled without
writing an artifact; direct perplexity-lite failed with a 401 insufficient-quota
error, so manual notes were started ingenes/human/PSEN1/PSEN1-notes.md. - Completed PSEN1 first-pass review: all 197 seeded GO annotations have review
actions, core gamma-secretase function is defined, knowledge gaps are in
genes/human/PSEN1/PSEN1-notes.md, andjust validate human PSEN1passes
cleanly. Action distribution: 65 ACCEPT, 52 KEEP_AS_NON_CORE, 57
MARK_AS_OVER_ANNOTATED, 7 MODIFY, 16 UNDECIDED. - Completed PSEN2 first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/PSEN2/PSEN2-notes.mdfrom cached UniProt/GOA/publication
evidence. All 79 seeded GO annotations have review actions, core PSEN2
gamma-secretase function is defined with late endosome/lysosome emphasis, and
just validate human PSEN2passes cleanly. Action distribution: 40 ACCEPT, 24
KEEP_AS_NON_CORE, 11 MARK_AS_OVER_ANNOTATED, 4 UNDECIDED. - Completed APOE first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/APOE/APOE-notes.mdfrom cached UniProt/GOA/publication evidence.
All 293 seeded GO annotations have review actions, core APOE
lipid-transfer/lipoprotein-clearance functions are defined, andjust validate human APOEpasses cleanly. Action distribution: 145 ACCEPT, 120
KEEP_AS_NON_CORE, 28 MARK_AS_OVER_ANNOTATED. - Completed TREM2 first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/TREM2/TREM2-notes.mdfrom cached UniProt/GOA/publication
evidence. All 273 seeded GO annotations have review actions, core TREM2
lipid/apolipoprotein ligand-sensing and TYROBP-linked receptor signaling
functions are defined, andjust validate human TREM2passes cleanly. Action
distribution: 117 ACCEPT, 151 KEEP_AS_NON_CORE, 5 MARK_AS_OVER_ANNOTATED. - Completed SORL1 first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/SORL1/SORL1-notes.mdfrom cached UniProt/GOA/publication
evidence. All 168 seeded GO annotations have review actions, core SORL1 cargo
receptor, APP/amyloid-beta sorting, and Golgi/endosomal trafficking functions
are defined, andjust validate human SORL1passes cleanly. Action
distribution: 92 ACCEPT, 44 KEEP_AS_NON_CORE, 25 MARK_AS_OVER_ANNOTATED, 4
MODIFY, 3 UNDECIDED. - Completed ABCA7 first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/ABCA7/ABCA7-notes.mdfrom cached UniProt/GOA/publication
evidence. All 81 seeded GO annotations have review actions, core ABCA7
ATP-coupled phospholipid transport, apoA-I phospholipid efflux, and
phagocytic/amyloid-clearance functions are defined, andjust validate human ABCA7passes cleanly. Action distribution: 55 ACCEPT, 20 KEEP_AS_NON_CORE, 4
MODIFY, 2 MARK_AS_OVER_ANNOTATED. - Completed ADAM10 first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/ADAM10/ADAM10-notes.mdfrom cached UniProt/GOA/publication
evidence. All 151 seeded GO annotations have review actions, core ADAM10
metalloendopeptidase/ectodomain-shedding, APP alpha-secretase, Notch, and
regulated membrane-localization functions are defined, andjust validate human ADAM10passes cleanly. Action distribution: 88 ACCEPT, 42
KEEP_AS_NON_CORE, 19 MARK_AS_OVER_ANNOTATED, 1 MODIFY, 1 REMOVE. - Fetched and seeded amyloid/gamma-secretase pathway batch data for BACE1,
NCSTN, APH1A, APH1B, and PSENEN. Seeded GOA annotation counts: BACE1 140,
NCSTN 99, APH1A 73, APH1B 43, PSENEN 71. - Completed BACE1 first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/BACE1/BACE1-notes.mdfrom cached UniProt/GOA/publication
evidence. All 140 seeded GO annotations have review actions, core BACE1
beta-secretase/aspartyl endopeptidase, APP beta-cleavage, amyloid-beta
formation, and TGN/endosomal trafficking functions are defined, andjust validate human BACE1passes cleanly. Action distribution: 94 ACCEPT, 24
KEEP_AS_NON_CORE, 20 MARK_AS_OVER_ANNOTATED, 2 MODIFY. - Completed NCSTN first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/NCSTN/NCSTN-notes.mdfrom cached UniProt/GOA/publication
evidence. All 99 seeded GO annotations have review actions, core nicastrin
gamma-secretase complex adaptor/substrate-recruitment contribution to
intramembrane aspartyl endopeptidase activity is defined, andjust validate human NCSTNpasses cleanly. Action distribution: 73 ACCEPT, 12
KEEP_AS_NON_CORE, 10 MARK_AS_OVER_ANNOTATED, 4 MODIFY. - Completed APH1A first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/APH1A/APH1A-notes.mdfrom cached UniProt/GOA/publication
evidence. All 73 seeded GO annotations have review actions, core APH1A
gamma-secretase complex adaptor/assembly contribution to intramembrane
aspartyl endopeptidase activity is defined, andjust validate human APH1A
passes cleanly. Action distribution: 50 ACCEPT, 12 KEEP_AS_NON_CORE, 9
MARK_AS_OVER_ANNOTATED, 2 MODIFY. - Completed APH1B first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/APH1B/APH1B-notes.mdfrom cached UniProt/GOA/publication
evidence. All 43 seeded GO annotations have review actions, core APH1B
gamma-secretase complex adaptor/assembly contribution to intramembrane
aspartyl endopeptidase activity is defined with APH1B-specific substrate
preference questions, andjust validate human APH1Bpasses cleanly. Action
distribution: 37 ACCEPT, 4 MARK_AS_OVER_ANNOTATED, 1 MODIFY, 1
KEEP_AS_NON_CORE. - Completed PSENEN first-pass review: falcon deep research timed out after 180
seconds without writing an artifact, so manual notes were created in
genes/human/PSENEN/PSENEN-notes.mdfrom cached UniProt/GOA/publication
evidence. All 71 seeded GO annotations have review actions, core PEN-2
gamma-secretase endopeptidase-activator contribution, presenilin
endoproteolysis, complex stability, trafficking, and APP/Notch processing
functions are defined, andjust validate human PSENENpasses cleanly. Action
distribution: 55 ACCEPT, 8 KEEP_AS_NON_CORE, 7 MARK_AS_OVER_ANNOTATED, 1
MODIFY. - Completed CLU second-pass cleanup: existing annotation reviews were already
present, but status was stillIN_PROGRESSand one repeated GO term had
inconsistent actions. Reconcilednegative regulation of protein-containing complex assemblyto ACCEPT, added the available falcon deep-research file as
supporting context, set status to COMPLETE, rendered the review, andjust validate human CLUnow passes cleanly. Action distribution: 73 ACCEPT, 56
KEEP_AS_NON_CORE, 22 MARK_AS_OVER_ANNOTATED, 4 MODIFY. - Completed BIN1 first-pass review: fetched gene data, GOA annotations,
publications, and PANTHER familyPTHR46514. Falcon deep research timed out
after 180 seconds without writing an artifact, so manual notes were created in
genes/human/BIN1/BIN1-notes.mdfrom cached UniProt/GOA/PANTHER/publication
evidence. All 112 seeded GO annotations have review actions, core BIN1
BAR-domain phospholipid/membrane-curvature, lipid tubulation, endocytosis,
clathrin/dynamin adaptor, synaptic vesicle, and T-tubule functions are
defined, andjust validate human BIN1passes cleanly. Action distribution:
62 ACCEPT, 31 KEEP_AS_NON_CORE, 18 MARK_AS_OVER_ANNOTATED, 1 MODIFY. - Completed PICALM first-pass review: fetched gene data, GOA annotations,
publications, and PANTHER familyPTHR22951. Falcon deep research timed out
after 180 seconds without writing an artifact, so manual notes were created in
genes/human/PICALM/PICALM-notes.mdfrom cached UniProt/GOA/Reactome/publication
evidence. All 113 seeded GO annotations have review actions, core PICALM
phosphoinositide-bound clathrin adaptor, coated-vesicle curvature/maturation,
clathrin coat assembly, and small R-SNARE cargo-sorting functions are defined,
andjust validate human PICALMpasses cleanly. Action distribution: 80
ACCEPT, 22 KEEP_AS_NON_CORE, 10 MARK_AS_OVER_ANNOTATED, 1 MODIFY. - Completed CD33 first-pass review: fetched gene data, GOA annotations,
publications, and PANTHER familyPTHR12035. Falcon deep research timed out
after 180 seconds without writing an artifact, so manual notes were created in
genes/human/CD33/CD33-notes.mdfrom cached UniProt/GOA/Reactome/PANTHER/publication
evidence. All 45 seeded GO annotations have review actions, core CD33/Siglec-3
sialic-acid binding, cell-surface inhibitory receptor signaling, ITIM-linked
SHP-1/SHP-2 recruitment, and negative myeloid/monocyte activation functions
are defined, andjust validate human CD33passes cleanly. Action
distribution: 29 ACCEPT, 5 KEEP_AS_NON_CORE, 8 MARK_AS_OVER_ANNOTATED, 2
MODIFY, 1 UNDECIDED. - Completed CR1 first-pass review: fetched gene data, GOA annotations,
publications, and confirmed existing PANTHER familyPTHR45656. Falcon deep
research timed out after 180 seconds without writing an artifact, so manual
notes were created ingenes/human/CR1/CR1-notes.mdfrom cached
UniProt/GOA/Reactome/PANTHER/publication evidence. All 64 seeded GO
annotations have review actions, core CR1/CD35 complement receptor activity,
C3b/C4b binding, immune-adherence clearance, factor I cofactor/convertase
decay, and negative complement-regulatory functions are defined, andjust validate human CR1passes cleanly. Action distribution: 42 ACCEPT, 17
KEEP_AS_NON_CORE, 3 MARK_AS_OVER_ANNOTATED, 2 MODIFY. - Completed CD2AP first-pass review: fetched gene data, GOA annotations,
publications, and confirmed existing PANTHER familyPTHR14167. Falcon deep
research timed out after 180 seconds without writing an artifact, so manual
notes were created ingenes/human/CD2AP/CD2AP-notes.mdfrom cached
UniProt/GOA/PANTHER/publication evidence. All 72 seeded GO annotations have
review actions, core CD2AP SH3-domain adaptor/scaffold, actin remodeling,
junction/slit-diaphragm, and endosomal trafficking functions are defined, and
just validate human CD2APpasses cleanly. Action distribution: 36 ACCEPT, 9
KEEP_AS_NON_CORE, 19 MARK_AS_OVER_ANNOTATED, 7 MODIFY, 1 UNDECIDED. - Completed INPP5D first-pass review: fetched gene data, GOA annotations,
publications, and PANTHER familyPTHR46051. Falcon deep research timed out
after 180 seconds without writing an artifact, so manual notes were created in
genes/human/INPP5D/INPP5D-notes.mdfrom cached
UniProt/GOA/Reactome/PANTHER/publication evidence. All 56 seeded GO
annotations have review actions, plus one NEW phosphotyrosine-residue binding
annotation was added to replace repeated generic protein-binding entries. Core
SHIP1 PtdIns(3,4,5)P3/IP4 5-phosphatase, phosphotyrosine-motif recruitment,
and immune receptor signal-attenuation functions are defined, andjust validate human INPP5Dpasses cleanly. Action distribution: 34 ACCEPT, 4
KEEP_AS_NON_CORE, 3 MARK_AS_OVER_ANNOTATED, 12 MODIFY, 2 UNDECIDED, 1 REMOVE,
1 NEW. - Completed PLCG2 first-pass review: fetched gene data, GOA annotations,
publications, and PANTHER familyPTHR10336. Falcon deep research timed out
after 180 seconds without writing an artifact, so manual notes were created in
genes/human/PLCG2/PLCG2-notes.mdfrom cached
UniProt/GOA/Reactome/PANTHER/publication evidence. All 167 seeded GO
annotations have review actions, core PLCG2 PIP2 phospholipase, IP3/DAG and
calcium signaling, phosphotyrosine-dependent recruitment, BCR/antigen/C-type
lectin receptor signaling, and membrane/raft/ruffle localization functions
are defined, andjust validate human PLCG2passes cleanly. Alzheimer-relevant
TREM2/TLR microglial phenotypes were retained as important non-core cellular
outcomes. Action distribution: 83 ACCEPT, 56 KEEP_AS_NON_CORE, 19 MODIFY, 7
MARK_AS_OVER_ANNOTATED, 1 UNDECIDED, 1 REMOVE. - Completed SPI1 first-pass review: fetched gene data, GOA annotations,
publications, and PANTHER familyPTHR11849. Falcon deep research timed out
after 180 seconds without writing an artifact, so manual notes were created in
genes/human/SPI1/SPI1-notes.mdfrom cached
UniProt/GOA/Reactome/PANTHER/publication evidence. Added the cached PU.1
macrophage binding-site selection paperPMID:23658224as an extra reference.
All 140 seeded GO annotations have review actions, core PU.1 ETS/PU-box
cis-regulatory DNA binding, RNA polymerase II transcription-factor activity,
pioneer/chromatin accessibility control, and B-cell/myeloid hematopoietic
lineage functions are defined, andjust validate human SPI1passes cleanly.
Microglial/macrophage and immune-output terms were retained as non-core where
they represent downstream cell-state consequences. Action distribution: 74
ACCEPT, 32 KEEP_AS_NON_CORE, 21 MODIFY, 11 MARK_AS_OVER_ANNOTATED, 2
UNDECIDED. - Completed MS4A4A first-pass review: fetched gene data, GOA annotations,
publications, and PANTHER familyPTHR23320. Falcon deep research timed out
after 180 seconds without writing an artifact, so manual notes were created in
genes/human/MS4A4A/MS4A4A-notes.mdfrom cached
UniProt/GOA/PANTHER/publication evidence. All 9 seeded GO annotations have
review actions, core four-pass MS4A4A membrane, plasma membrane raft, Golgi,
and endoplasmic reticulum localization is defined, andjust validate human MS4A4Apasses cleanly. Generic interactome protein-binding annotations were
marked over-annotated; TREM2/sTREM2 modulation was recorded as an
Alzheimer-relevant unresolved biological question rather than an invented
molecular function. Action distribution: 7 ACCEPT, 2
MARK_AS_OVER_ANNOTATED. - Completed MS4A6A first-pass review: fetched gene data, GOA annotations,
publications, and confirmed PANTHER familyPTHR23320. Falcon deep research
timed out after 180 seconds without writing an artifact, so manual notes were
created ingenes/human/MS4A6A/MS4A6A-notes.mdfrom cached
UniProt/GOA/PANTHER/publication evidence. All 6 seeded GO annotations have
review actions, core MS4A6A four-pass membrane/trans-Golgi localization is
defined, andjust validate human MS4A6Apasses cleanly. The plasma-membrane
IBA was modified to the directly supported trans-Golgi network term, while
broad receptor-signaling and generic protein-binding annotations were marked
over-annotated. Action distribution: 3 ACCEPT, 2
MARK_AS_OVER_ANNOTATED, 1 MODIFY. - Completed EPHA1 first-pass review: fetched gene data, GOA annotations,
publications, Reactome records, and PANTHER familyPTHR46877. Falcon deep
research timed out after 180 seconds without writing an artifact, so manual
notes were created ingenes/human/EPHA1/EPHA1-notes.mdfrom cached
UniProt/GOA/Reactome/PANTHER/publication evidence. All 42 seeded GO
annotations have review actions, core EPHA1 transmembrane ephrin receptor and
receptor protein tyrosine kinase functions are defined, andjust validate human EPHA1passes cleanly. Context-dependent adhesion, migration,
angiogenesis, fibronectin-binding, and kinase-binding outputs were kept as
non-core; indirect stress-fiber assembly transfers were marked
over-annotated. Action distribution: 30 ACCEPT, 10 KEEP_AS_NON_CORE, 2
MARK_AS_OVER_ANNOTATED. - Completed FERMT2 first-pass review: fetched gene data, GOA annotations,
publications, Reactome records, and PANTHER familyPTHR16160. Falcon deep
research timed out after 180 seconds without writing an artifact, so manual
notes were created ingenes/human/FERMT2/FERMT2-notes.mdfrom cached
UniProt/GOA/Reactome/PANTHER/publication evidence. All 85 seeded GO
annotations have review actions, core kindlin-2 integrin-binding/co-activator,
phosphoinositide/PIP3 membrane-engagement, and actin/ILK-linked
focal-adhesion scaffold functions are defined, andjust validate human FERMT2passes cleanly. Wnt, TGF-beta/Smad, EMT, endothelial barrier,
trophoblast migration, and MSC fate outputs were kept as non-core; generic
protein-binding and imprecise cell-surface terms were modified to more
informative replacements. Action distribution: 52 ACCEPT, 30
KEEP_AS_NON_CORE, 3 MODIFY. - Completed CASS4 first-pass review: fetched gene data, GOA annotations,
publications, and confirmed PANTHER familyPTHR10654. Falcon deep research
timed out after 180 seconds without writing an artifact, so manual notes were
created ingenes/human/CASS4/CASS4-notes.mdfrom cached
UniProt/GOA/PANTHER/publication evidence. All 15 seeded GO annotations have
review actions, core CASS4/HEPL Cas-family focal-adhesion docking/scaffold,
FAK/protein-tyrosine-kinase binding/regulation, cell spreading, and migration
functions are defined, andjust validate human CASS4passes cleanly. The
broad receptor-tyrosine-kinase signaling IBA was modified to
integrin-mediated signaling; AKT pathway activation was kept as non-core NSCLC
context. Action distribution: 13 ACCEPT, 1 KEEP_AS_NON_CORE, 1 MODIFY. - Completed MAPT first-pass review: fetched gene data, 198 GOA annotations,
publications, and confirmed PANTHER familyPTHR11501. Falcon deep research
timed out after 180 seconds without writing an artifact, so manual notes were
created ingenes/human/MAPT/MAPT-notes.mdfrom cached
UniProt/GOA/PANTHER/publication evidence. All seeded annotations have review
actions, core tau microtubule-stabilizing/axon/membrane-cortex linker
function and Alzheimer-relevant tau self-assembly/neurofibrillary-tangle
pathology are defined, andjust validate human MAPTpasses cleanly. Synaptic,
mitochondrial, secretion, glial, stress-response, nuclear, and partner-binding
contexts were kept as non-core where credible; genericprotein bindingand
broad nucleic-acid/process terms were marked over-annotated. Thepart_of tubulin complexannotation was modified to tubulin binding. Action
distribution: 77 ACCEPT, 70 KEEP_AS_NON_CORE, 50 MARK_AS_OVER_ANNOTATED, 1
MODIFY. - Completed GSK3B first-pass review: fetched gene data, 390 GOA annotations,
publications, Reactome-derived entries, and confirmed PANTHER family
PTHR24057. Falcon deep research timed out after 180 seconds without writing
an artifact, so manual notes were created in
genes/human/GSK3B/GSK3B-notes.mdfrom cached
UniProt/GOA/Reactome/PANTHER/publication evidence. All seeded annotations have
review actions, core GSK3B ATP-dependent protein serine/threonine kinase,
tau-protein kinase, Wnt/beta-catenin destruction-complex, protein-turnover,
and glycogen/insulin metabolic-regulation functions are defined, andjust validate human GSK3Bpasses cleanly. Broad apoptosis, EMT, ER-stress, mTOR,
cilia, circadian, immune, synaptic, developmental, and centrosomal outputs were
kept as non-core; genericprotein bindingand broad signal-transduction
terms were marked over-annotated; generic kinase terms were modified to
protein serine/threonine kinase activity. Action distribution: 172 ACCEPT, 126
KEEP_AS_NON_CORE, 84 MARK_AS_OVER_ANNOTATED, 8 MODIFY. - Completed LRP1 first-pass review: fetched gene data, 124 GOA annotations,
publications, and confirmed PANTHER familyPTHR22722. Falcon deep research
timed out after 180 seconds without writing an artifact, so manual notes were
created ingenes/human/LRP1/LRP1-notes.mdfrom cached
UniProt/GOA/PANTHER/publication evidence. All seeded annotations have review
actions, core LRP1 LDLR-family cargo/scavenger receptor, apolipoprotein and
lipoprotein receptor, receptor-mediated endocytosis/internalization, amyloid
beta clearance/transcytosis, blood-brain-barrier transport, and tau/MAPT uptake
context are defined, andjust validate human LRP1passes cleanly. Vascular,
extracellular-matrix, inflammatory, infection/toxin, intracellular-domain, and
signaling side branches were kept as non-core; generic protein/RNA/complex
binding and broad signaling-receptor labels were marked over-annotated. Action
distribution: 77 ACCEPT, 29 KEEP_AS_NON_CORE, 18 MARK_AS_OVER_ANNOTATED. - Completed ABCA1 first-pass review: fetched gene data, 145 GOA annotations,
publication caches, Reactome-derived entries, and confirmed the UniProt/PANTHER
ABCA-family assignmentPTHR19229:SF34. Falcon deep research timed out after
180 seconds without writing an artifact, so manual notes were created in
genes/human/ABCA1/ABCA1-notes.mdfrom cached
UniProt/GOA/Reactome/publication evidence. All seeded annotations have review
actions, core ABCA1 ATP-coupled phospholipid transporter/floppase activity,
apoA-I/apoE-linked lipidation and nascent HDL assembly, cholesterol efflux,
reverse cholesterol transport, and plasma-membrane/endosomal localization are
defined, andjust validate human ABCA1passes cleanly. ApoA-I-triggered
Cdc42/cAMP signaling, response/stimulus terms, ER/Golgi/perinuclear
trafficking, platelet dense-granule and protein-secretion outputs were kept as
non-core; generic binding and protein-cargo transport labels were
over-annotated or modified to lipid-specific replacements. Action distribution:
94 ACCEPT, 34 KEEP_AS_NON_CORE, 11 MARK_AS_OVER_ANNOTATED, 6 MODIFY. - Completed ABI3 cleanup review: the existing Falcon deep-research-backed ABI3
review was markedCOMPLETE, duplicatedefense response to tumor cell
actions were aligned as non-core, and the Falcon deep-research report was
cited in the core WAVE regulatory complex synthesis. All 47 seeded annotations
have review actions, core ABI3/NESH signaling-adaptor membership in the SCAR/WAVE
regulatory complex, actin-dependent migration/protrusion control, and
lamellipodium regulation are defined, andjust validate human ABI3passes
cleanly. Action distribution: 25 ACCEPT, 12 KEEP_AS_NON_CORE, 9
MARK_AS_OVER_ANNOTATED, 1 UNDECIDED.
2026-06-20
- Completed APP second-pass review cleanup: revised the standalone biological
description, added local UniProt and Falcon deep-research references, added
NEW review entries for APP cell-adhesion mediator activity, cell-adhesion
molecule binding, and copper ion binding, and aligned duplicate-term actions
for broad protein-metabolism, interleukin-1-response, and amyloid-beta LTP
annotations. Knowledge-gap questions and suggested experiments now focus on
evolved in-vivo APP isoform, fragment, adhesion, trophic-signaling,
metal-binding, and intracellular-domain biology.just validate human APPand
just render human APPpass cleanly. Action distribution: 251 ACCEPT, 80
KEEP_AS_NON_CORE, 91 MARK_AS_OVER_ANNOTATED, 3 NEW, 1 REMOVE, 3 UNDECIDED
across 429 annotations. - Completed CLU second-pass review cleanup: added
genes/human/CLU/CLU-notes.md, recorded manual reference-review metadata for
the Falcon deep-research report, and added knowledge-gap questions plus
suggested experiments focused on evolved in-vivo CLU extracellular holdase,
complement MAC-inhibition, receptor-mediated client clearance, glycoform/redox
regulation, and isoform biology.just validate human CLUandjust render human CLUpass cleanly. Action distribution: 73 ACCEPT, 56 KEEP_AS_NON_CORE,
22 MARK_AS_OVER_ANNOTATED, 4 MODIFY across 155 annotations. - Completed ABI3 notes backfill: added
genes/human/ABI3/ABI3-notes.mdto
capture WRC/adaptor, microglial actin-surveillance, phosphorylation, S209F,
and model-interpretation evidence from UniProt, primary review citations, and
the Falcon report. No YAML action changes were needed in this pass;just validate human ABI3passes cleanly. - Completed PSEN1 second-pass audit: added
reference_reviewmetadata for the
core gamma-secretase complex/substrate paper (PMID:15274632), the human
gamma-secretase structure paper (PMID:26280335), and the ER calcium-leak paper
(PMID:16959576), and appended notes explaining why unusual location
annotations remain UNDECIDED pending fuller evidence. No annotation action
changes were made;just validate human PSEN1andjust render human PSEN1
pass cleanly. Action distribution: 65 ACCEPT, 52 KEEP_AS_NON_CORE, 57
MARK_AS_OVER_ANNOTATED, 7 MODIFY, 16 UNDECIDED across 197 annotations. - Completed PSEN2 second-pass audit: added
reference_reviewmetadata for APP
and Notch processing, PSEN2 catalytic aspartate, AP-1-dependent
late-endosome/lysosome localization, and ER-mitochondria calcium-coupling
evidence (PMIDs 15274632, 10497236, 10652302, 27293189, 21285369). The
remaining UNDECIDED calls were left unchanged because they are hypoxia or
specific synaptic-location transfers without direct cached support.just validate human PSEN2andjust render human PSEN2pass cleanly. Action
distribution: 40 ACCEPT, 24 KEEP_AS_NON_CORE, 11 MARK_AS_OVER_ANNOTATED, 4
UNDECIDED across 79 annotations. - Completed SORL1 second-pass audit: added
reference_reviewmetadata for the
core APP/SORLA trafficking and amyloid-beta lysosomal-sorting evidence
(PMIDs 16174740, 16407538, 17855360, 22621900, 24523320), and appended notes
explaining why the remaining nuclear-envelope style localization annotations
remain UNDECIDED. No annotation actions were changed;just validate human SORL1andjust render human SORL1pass cleanly. Action distribution: 92
ACCEPT, 44 KEEP_AS_NON_CORE, 25 MARK_AS_OVER_ANNOTATED, 4 MODIFY, 3
UNDECIDED across 168 annotations. - Completed ADAM10 second-pass audit: added
reference_reviewmetadata for the
main ectodomain-shedding, APP alpha-secretase, synaptic endocytosis,
L1-cleavage, and S. aureus alpha-toxin context papers (PMIDs 26686862,
33731436, 23676497, 12475894, 30463011). The existing REMOVE for
metallodipeptidase activity was retained because ADAM10 is a membrane
metalloendopeptidase/sheddase, not a dipeptidase.just validate human ADAM10andjust render human ADAM10pass cleanly. Action distribution: 88
ACCEPT, 42 KEEP_AS_NON_CORE, 19 MARK_AS_OVER_ANNOTATED, 1 MODIFY, 1 REMOVE
across 151 annotations. - Completed INPP5D second-pass audit: reviewed the remaining REMOVE and
UNDECIDED calls against cached evidence and appended notes. The NKG2A
protein-binding annotation remains REMOVE because the cached PMID:9485206
abstract explicitly says SHIP is not associated; the two remaining experimental
protein-binding annotations remain UNDECIDED because abstract-only evidence
does not expose SHIP1-specific support. No YAML action changes were needed;
just validate human INPP5Dpasses cleanly. Action distribution remains 34
ACCEPT, 4 KEEP_AS_NON_CORE, 12 MODIFY, 3 MARK_AS_OVER_ANNOTATED, 2 UNDECIDED,
1 REMOVE, 1 NEW across 57 annotations. - Completed PLCG2 second-pass audit: reviewed the remaining UNDECIDED and REMOVE
calls against cached evidence and appended notes. The protein tyrosine kinase
binding IPI remains UNDECIDED because PMID:32514138 is abstract-only in cache,
while the Wnt signaling annotation remains REMOVE because PMID:18784435 does
not support PLCG2 function in Wnt signaling. No YAML action changes were
needed;just validate human PLCG2passes cleanly. Action distribution
remains 83 ACCEPT, 56 KEEP_AS_NON_CORE, 19 MODIFY, 7
MARK_AS_OVER_ANNOTATED, 1 UNDECIDED, 1 REMOVE across 167 annotations. - Completed CD33 second-pass audit: reviewed the remaining UNDECIDED
tau/protein-secretion annotation and appended notes. The PMID:27044754 cache
names FRMD4A as the functional tau-release hit and does not expose the
CD33-specific IMP evidence, so the annotation remains UNDECIDED rather than
removed. No YAML action changes were needed;just validate human CD33passes
cleanly. Action distribution remains 29 ACCEPT, 5 KEEP_AS_NON_CORE, 8
MARK_AS_OVER_ANNOTATED, 2 MODIFY, 1 UNDECIDED across 45 annotations. - Completed CD2AP second-pass audit: reviewed the remaining UNDECIDED
tau/protein-secretion annotation and appended notes. The PMID:27044754 cache
is abstract-only and foregrounds FRMD4A rather than CD2AP-specific evidence,
so the experimental annotation remains UNDECIDED pending full-text or
supplementary-data review. No YAML action changes were needed;just validate human CD2APpasses cleanly. Action distribution remains 36 ACCEPT, 9
KEEP_AS_NON_CORE, 19 MARK_AS_OVER_ANNOTATED, 7 MODIFY, 1 UNDECIDED across 72
annotations. - Completed SPI1 second-pass audit: reviewed the two remaining generic
protein bindingIPI annotations against the cached abstracts and appended
notes. PMID:21575865 foregrounds TMPRSS2:ERG interaction evidence and
PMID:10207087 foregrounds MEF/AML1 interaction evidence, so both SPI1
experimental annotations remain UNDECIDED pending full-text or
supplementary-data review rather than being removed. No YAML action changes
were needed. Action distribution remains 74 ACCEPT, 32 KEEP_AS_NON_CORE, 21
MODIFY, 11 MARK_AS_OVER_ANNOTATED, 2 UNDECIDED across 140 annotations. - Completed NCSTN second-pass audit: added
reference_reviewmetadata for the
core nicastrin/gamma-secretase complex, APP/Notch proteolysis, and structural
references. No annotation action changes were needed;just validate human NCSTNandjust render human NCSTNpass cleanly. Action distribution remains
73 ACCEPT, 12 KEEP_AS_NON_CORE, 10 MARK_AS_OVER_ANNOTATED, 4 MODIFY across 99
annotations. - Completed APH1A second-pass audit: added
reference_reviewmetadata for the
main APH-1/gamma-secretase association, substrate processing, purified-complex
and structural references. No annotation action changes were needed;just validate human APH1Aandjust render human APH1Apass cleanly. Action
distribution remains 50 ACCEPT, 12 KEEP_AS_NON_CORE, 9
MARK_AS_OVER_ANNOTATED, 2 MODIFY across 73 annotations. - Completed APH1B second-pass audit: added
reference_reviewmetadata for
APH1B-relevant APH-1 and isoform-specific gamma-secretase references. No
annotation action changes were needed;just validate human APH1Bandjust render human APH1Bpass cleanly. Action distribution remains 37 ACCEPT, 1
KEEP_AS_NON_CORE, 4 MARK_AS_OVER_ANNOTATED, 1 MODIFY across 43 annotations. - Completed PSENEN second-pass audit: added
reference_reviewmetadata for
PEN-2 complex membership, presenilin endoproteolysis, gamma-secretase
activity, and structural references. No annotation action changes were needed;
just validate human PSENENandjust render human PSENENpass cleanly.
Action distribution remains 55 ACCEPT, 8 KEEP_AS_NON_CORE, 7
MARK_AS_OVER_ANNOTATED, 1 MODIFY across 71 annotations. - Completed APOE second-pass audit: added
reference_reviewmetadata for the
key lipid-efflux, astrocyte lipoprotein-release, receptor-mediated
lipoprotein uptake, amyloid-beta binding, and TREM2-ligand references. No
annotation action changes were needed;just validate human APOEandjust render human APOEpass cleanly. Action distribution remains 145 ACCEPT, 120
KEEP_AS_NON_CORE, 28 MARK_AS_OVER_ANNOTATED across 293 annotations. - Completed TREM2 second-pass audit: added
reference_reviewmetadata for the
DAP12 receptor-signaling, apolipoprotein/amyloid/apoptotic-cell ligand,
myelin-cholesterol response, and human microglia loss-of-function references.
No annotation action changes were needed;just validate human TREM2and
just render human TREM2pass cleanly. Action distribution remains 117
ACCEPT, 151 KEEP_AS_NON_CORE, 5 MARK_AS_OVER_ANNOTATED across 273
annotations. - Completed ABCA7 second-pass audit: added
reference_reviewmetadata for
phospholipid efflux, apolipoprotein binding, reconstituted phospholipid
transport, lysophosphatidylcholine export, and APP/amyloid-processing
references. No annotation action changes were needed;just validate human ABCA7andjust render human ABCA7pass cleanly. Action distribution
remains 55 ACCEPT, 20 KEEP_AS_NON_CORE, 4 MODIFY, 2 MARK_AS_OVER_ANNOTATED
across 81 annotations. - Completed BACE1 second-pass audit: added
reference_reviewmetadata for
beta-secretase discovery, APP beta-site cleavage, late-Golgi/APP-access
localization, and GGA/SNX6 trafficking-control references. No annotation
action changes were needed;just validate human BACE1andjust render human BACE1pass cleanly. Action distribution remains 94 ACCEPT, 24
KEEP_AS_NON_CORE, 20 MARK_AS_OVER_ANNOTATED, 2 MODIFY across 140 annotations. - Completed BIN1 second-pass audit: added
reference_reviewmetadata for
BAR/N-BAR membrane curvature, membrane tubulation, DNM2 interaction,
BIN1-BACE1 trafficking, and BIN1/tau/clusterin references. No annotation
action changes were needed;just validate human BIN1andjust render human BIN1pass cleanly. Action distribution remains 62 ACCEPT, 31
KEEP_AS_NON_CORE, 18 MARK_AS_OVER_ANNOTATED, 1 MODIFY across 112 annotations. - Completed CDK5 second-pass audit: added
reference_reviewmetadata for p35
activation, p25 structural context, SH3GLB1/endophilin-B1 autophagy
phosphorylation, NR2B regulation, and the p35-specific microtubule-binding
caveat. No annotation action changes were needed;just validate human CDK5
andjust render human CDK5pass cleanly. Action distribution remains 76
ACCEPT, 30 KEEP_AS_NON_CORE, 38 MARK_AS_OVER_ANNOTATED, 5 MODIFY across 149
annotations. - Completed CDK5R1 second-pass audit: added
reference_reviewmetadata for
p35/CDK5 activation, p35-to-p25 conversion, CDK5/p25 structure, p35
microtubule binding, p35 myristoylation/localization, and CDK5-mediated
induced-autophagy context. No annotation action changes were needed;just validate human CDK5R1andjust render human CDK5R1pass cleanly. Action
distribution remains 61 ACCEPT, 16 KEEP_AS_NON_CORE, 19
MARK_AS_OVER_ANNOTATED, 8 MODIFY across 104 annotations. - Completed notes-only second-pass confirmations for PICALM, CR1, MS4A4A,
MS4A6A, EPHA1, FERMT2, CASS4, MAPT, GSK3B, LRP1, and ABCA1. These reviews
already had manualreference_reviewcoverage, no UNDECIDED calls, and no
REMOVE calls; no YAML action changes were needed.just validatepasses
cleanly for all eleven genes. Action distributions remain: PICALM 80 ACCEPT,
22 KEEP_AS_NON_CORE, 10 MARK_AS_OVER_ANNOTATED, 1 MODIFY; CR1 42 ACCEPT, 17
KEEP_AS_NON_CORE, 2 MODIFY, 3 MARK_AS_OVER_ANNOTATED; MS4A4A 7 ACCEPT, 2
MARK_AS_OVER_ANNOTATED; MS4A6A 3 ACCEPT, 1 MODIFY, 2
MARK_AS_OVER_ANNOTATED; EPHA1 30 ACCEPT, 10 KEEP_AS_NON_CORE, 2
MARK_AS_OVER_ANNOTATED; FERMT2 52 ACCEPT, 30 KEEP_AS_NON_CORE, 3 MODIFY; CASS4
13 ACCEPT, 1 MODIFY, 1 KEEP_AS_NON_CORE; MAPT 77 ACCEPT, 70 KEEP_AS_NON_CORE,
50 MARK_AS_OVER_ANNOTATED, 1 MODIFY; GSK3B 172 ACCEPT, 126
KEEP_AS_NON_CORE, 84 MARK_AS_OVER_ANNOTATED, 8 MODIFY; LRP1 77 ACCEPT, 29
KEEP_AS_NON_CORE, 18 MARK_AS_OVER_ANNOTATED; ABCA1 94 ACCEPT, 34
KEEP_AS_NON_CORE, 11 MARK_AS_OVER_ANNOTATED, 6 MODIFY. - Retired the disease-project overview module from
modules/. The Alzheimer
disease gene set, rationale, and pathway relevance remain in this project page;
future reusable module YAMLs should be normal biological modules, such as APP
processing, gamma-secretase-mediated intramembrane proteolysis,
apolipoprotein/lipoprotein transport, microglial lipid-debris sensing, tau
microtubule biology, or endocytic adaptor trafficking.
Slides
- Slides (Marp source: ALZHEIMER_DISEASE-slides.md) — AI generated